Home > Financial Ratios > NEULAND LABORATORIES

NEULAND LABORATORIES
Core EBITDA Margin

    Back to All Ratios
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results

NEULAND LABORATORIES Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Margin(%) 21.8929.6822.8215.0015.67

What is the latest Core EBITDA Margin ratio of NEULAND LABORATORIES ?

The latest Core EBITDA Margin ratio of NEULAND LABORATORIES is 21.89 based on Mar2025 Consolidated results.
Year Core EBITDA Margin
Mar202521.89
Mar202429.68
Mar202322.82
Mar202215.00
Mar202115.67

How is Core EBITDA Margin of NEULAND LABORATORIES Trending?

Years Core EBITDA Margin % Change
Mar2025 21.89
-26.25
Mar2024 29.68
30.06
Mar2023 22.82
52.13
Mar2022 15
-4.28
Mar2021 15.67 -

Other Financial Ratios of NEULAND LABORATORIES


Compare Core EBITDA Margin ratio of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹18,232.3 Cr -2.5% 16.4% 70.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,267.0 Cr 0.7% 2.8% 7.9% Stock Analytics
DIVIS LABORATORIES ₹178,672.0 Cr -0.8% 3.7% 48.6% Stock Analytics
CIPLA ₹119,713.0 Cr -0.2% -0.1% -1.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,195.0 Cr 3.4% 11.2% 17.9% Stock Analytics
DR REDDYS LABORATORIES ₹104,999.0 Cr 0.6% -5.2% -4.9% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

-2.5%

16.4%

70.8%

SENSEX

-0.9%

0.4%

1.4%


You may also like the below Video Courses